The AMD Center

Filter Your Results




Improving Outcomes in Neovascular AMD With Combination Intra…

Neovascular, or wet, age-related macular degeneration (AMD) is a multifactorial disease. Several studies have demons…

Jeffrey S. Heier, MD

Combination Therapy for Neovascular AMD

Anti-VEGF therapy has significantly improved the care of patients with neovascular, or wet, age-related macular dege…

Glenn J. Jaffe, MD

Other Anti-VEGF/Anti-PDGF Combination Drugs in the Pipeline …

VEGF and PDGF are two common and critical pathways implicated in serious retinal diseases and a combination treatment of…

the staff of Retina Today


CATT 5-Year Data Released The 5-year results of the CATT, a clinical trial assessing the role of anti-VEGF therapy in…

Advances in Therapy for Dry AMD

Among the multitude of age-related conditions we face is age-related macular degeneration (AMD). The risk of AMD inc…

Aron Shapiro

ASSESS Study - 24 Months

Rishi P. Singh, MD, reviews details of the ASSESS study, which transitioned patients who had previously been treated wit…

Rishi P. Singh, MD

Drug Selection and Patient Outcomes in AMD

David Eichenbaum, MD, demonstrates how drug selection can affect outcomes over time by sharing the cases of two patients…

David Eichenbaum, MD

Potential Treatments for AMD

Thomas Ciulla, MD, describes a study designed to address an unmet need in AMD. Anti-VEGF therapy is very effective in th…

Thomas Ciulla, MD


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.